tradingkey.logo

Medicus Pharma Ltd

MDCX
View Detailed Chart

2.570USD

0.0000.00%
Close 08/01, 16:00ETQuotes delayed by 15 min
34.48MMarket Cap
LossP/E TTM

Medicus Pharma Ltd

2.570

0.0000.00%
Intraday
1m
30m
1h
D
W
M
D

Today

+4.47%

5 Days

-12.29%

1 Month

-23.96%

6 Months

+0.78%

Year to Date

+5.76%

1 Year

0.00%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 3 analysts
BUY
Current Rating
19.667
Target Price
665.24%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

173
Total
5
Median
8
Average
Company name
Ratings
Analysts
Medicus Pharma Ltd
MDCX
3
Biogen Inc
BIIB
37
Alnylam Pharmaceuticals Inc
ALNY
34
Vertex Pharmaceuticals Inc
VRTX
34
Amgen Inc
AMGN
33
Gilead Sciences Inc
GILD
30
1
2
3
...
35

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Sell
Sell(7)
Neutral(3)
Buy(2)
Indicators
Sell(2)
Neutral(3)
Buy(1)
Indicators
Value
Direction
MACD(12,26,9)
-0.086
Sell
RSI(14)
40.520
Neutral
STOCH(KDJ)(9,3,3)
18.867
Neutral
ATR(14)
0.211
High Vlolatility
CCI(14)
-92.066
Neutral
Williams %R
80.537
Oversold
TRIX(12,20)
-0.585
Sell
StochRSI(14)
100.000
Buy
Moving Average
Sell(5)
Neutral(0)
Buy(1)
Indicators
Value
Direction
MA5
2.512
Buy
MA10
2.770
Sell
MA20
2.961
Sell
MA50
3.228
Sell
MA100
3.649
Sell
MA200
3.312
Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Medicus Pharma Ltd. is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutic assets. Its subsidiaries include SkinJect, Inc, and Medicus Pharma Inc. The Company’s wholly owned subsidiary, SkinJect, Inc (SkinJect), is focused on commercializing a novel, non-invasive treatment for basal cell skin cancer using a patented dissolvable microneedle patch to deliver chemotherapeutic agent to eradicate tumor cells. The Company’s wholly owned subsidiaries are focused on the development of a drug delivery system using a dissolvable microneedle array for the treatment of certain skin cancers. The Company investigates opportunities across all therapeutic areas where an unmet need exists for improved patient safety and efficacy. The Company is actively exploring expanding its drug development pipeline through qualified and accretive acquisitions and partnerships.
Ticker SymbolMDCX
CompanyMedicus Pharma Ltd
CEODr. Raza Bokhari, M.D.
Websitehttps://medicuspharma.com/
KeyAI